Petros Family Wealth LLC Purchases 182 Shares of Intuitive Surgical, Inc. $ISRG

Petros Family Wealth LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,341 shares of the medical equipment provider’s stock after buying an additional 182 shares during the quarter. Intuitive Surgical accounts for about 1.2% of Petros Family Wealth LLC’s portfolio, making the stock its 21st biggest holding. Petros Family Wealth LLC’s holdings in Intuitive Surgical were worth $1,272,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Norway Savings Bank grew its stake in Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after purchasing an additional 910 shares in the last quarter. IronOak Wealth LLC. bought a new position in Intuitive Surgical in the second quarter valued at approximately $1,099,000. Trust Co. of Oklahoma bought a new position in Intuitive Surgical in the second quarter valued at approximately $363,000. Neville Rodie & Shaw Inc. boosted its stake in shares of Intuitive Surgical by 11.9% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after acquiring an additional 1,110 shares during the period. Finally, Banque Pictet & Cie SA boosted its stake in shares of Intuitive Surgical by 12.1% during the 2nd quarter. Banque Pictet & Cie SA now owns 37,768 shares of the medical equipment provider’s stock worth $20,524,000 after acquiring an additional 4,085 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the transaction, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 over the last ninety days. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on ISRG shares. Piper Sandler reiterated an “overweight” rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. UBS Group lifted their price target on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a report on Wednesday, July 23rd. Royal Bank Of Canada reissued an “outperform” rating and set a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $571.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 1st. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $594.19.

Intuitive Surgical Stock Performance

ISRG stock opened at $452.35 on Monday. The stock’s 50 day simple moving average is $463.55 and its 200 day simple moving average is $500.11. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The company has a market cap of $162.16 billion, a P/E ratio of 63.09, a price-to-earnings-growth ratio of 4.74 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.78 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.